LDLR	B:C1366529
,	O
ApoB	B:C1412471
and	O
ApoE	B:C1412481
genes	I:C1412481
polymorphisms	O
and	O
classical	O
risk	B:C0035648
factors	I:C0035648
in	O
premature	B:C1867743
coronary	I:C1867743
artery	I:C1867743
disease	I:C1867743
.	O

Lipoproteins	B:C0023820
play	O
a	O
central	O
role	O
in	O
the	O
development	O
of	O
atherosclerotic	B:C0004153
disease	I:C0004153
.	O

So	O
,	O
with	O
their	O
ability	O
to	O
affect	O
lipid	B:C0428460
levels	I:C0428460
,	O
the	O
LDLR	B:C1366529
,	O
ApoB	B:C1412471
and	O
ApoE	B:C1412481
polymorphisms	O
could	O
be	O
one	O
of	O
the	O
factors	O
influencing	O
development	O
of	O
atherosclerosis	B:C0004153
.	O

This	O
hypothesis	O
has	O
been	O
tested	B:C0392366
in	O
different	O
populations	O
with	O
conflicting	O
results	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
the	O
LDLR	B:C1366529
,	O
ApoB	B:C1412471
and	O
ApoE	B:C1412481
genes	I:C1412481
polymorphisms	O
with	O
premature	B:C1867743
CAD	I:C1867743
(	O
premature	B:C1867743
CAD	I:C1867743
)	O
in	O
Egyptians	B:C0337801
.	O

One	O
hundred	O
thirty	O
-	O
five	O
patients	O
of	O
premature	B:C1867743
CAD	I:C1867743
and	O
one	O
hundred	O
thirty	O
-	O
two	O
ages	O
and	O
sex	O
matched	O
control	O
subjects	O
were	O
included	O
in	O
the	O
study	O
.	O

LDLR	B:C1366529
and	O
ApoB	B:C1412471
genes	I:C1412471
polymorphisms	O
were	O
analyzed	B:C0936012
by	O
polymerase	B:C0032520
chain	I:C0032520
reaction	I:C0032520
(	O
polymerase	B:C0032520
chain	I:C0032520
reaction	I:C0032520
)	O
.	O

The	O
ApoE	B:C1412481
genotypes	O
were	O
identified	O
by	O
multiplex	B:C2732542
amplification	I:C2732542
refractory	I:C2732542
mutation	I:C2732542
system	I:C2732542
(	O
multiplex	B:C2732542
amplification	I:C2732542
refractory	I:C2732542
mutation	I:C2732542
system	I:C2732542
)	O
.	O

We	O
found	O
that	O
LDLR	B:C1366529
A	I:C1366529
(	I:C1366529
+)	I:C1366529
A(+	I:C1366529
)	I:C1366529
genotype	O
,	O
ApoB	B:C1412471
X	I:C1412471
(+	I:C1412471
)	I:C1412471
allele	B:C0002085
and	O
ApoE	B:C1412481
E4	I:C1412481
allele	B:C0002085
increased	O
the	O
risk	O
of	O
premature	B:C1867743
CAD	I:C1867743
by	O
1.8	O
,	O
2.1	O
and	O
12.1	O
respectively	O
.	O

The	O
present	O
study	O
proved	O
that	O
smoking	O
,	O
metabolic	B:C0524620
syndrome	I:C0524620
,	O
ApoB	B:C1412471
X	I:C1412471
(	I:C1412471
+	I:C1412471
)	I:C1412471
X(+	I:C1412471
)	I:C1412471
genotype	O
and	O
ApoE	B:C1412481
E4	I:C1412481
allele	B:C0002085
were	O
independent	O
risk	B:C0035648
factors	I:C0035648
for	O
the	O
development	O
of	O
premature	B:C1867743
CAD	I:C1867743
.	O

This	O
is	O
the	O
first	O
study	O
investigate	O
the	O
association	O
between	O
low	B:C1366529
density	I:C1366529
lipoprotein	I:C1366529
receptor	I:C1366529
,	O
apolipoprotein	B:C1412471
B	I:C1412471
and	O
apolipoprotein	B:C1412481
E	I:C1412481
genes	I:C1412481
polymorphisms	O
with	O
premature	B:C1867743
CAD	I:C1867743
and	O
lipid	B:C0428460
levels	I:C0428460
in	O
Egyptians	B:C0337801
and	O
we	O
concluded	O
that	O
the	O
LDLR	B:C1366529
A	I:C1366529
(	I:C1366529
+)	I:C1366529
A(+	I:C1366529
)	I:C1366529
genotype	O
,	O
ApoB	B:C1412471
X	I:C1412471
(+	I:C1412471
)	I:C1412471
allele	B:C0002085
and	O
ApoE	B:C1412481
E4	I:C1412481
allele	B:C0002085
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
development	O
of	O
premature	B:C1867743
CAD	I:C1867743
by	O
elevated	O
levels	B:C0201950
of	I:C0201950
total	I:C0201950
cholesterol	I:C0201950
(	I:C0201950
TC	I:C0201950
)	I:C0201950
and	O
low	B:C0202116
density	I:C0202116
lipoprotein	I:C0202116
(	O
LDLc	B:C0202116
)	O
.	O

The	O
coexistence	O
of	O
CAD	B:C1867743
risk	B:C0035648
factors	I:C0035648
with	O
LDLR	B:C1366529
A	I:C1366529
(	I:C1366529
+)	I:C1366529
A(+	I:C1366529
)	I:C1366529
genotype	O
,	O
ApoB	B:C1412471
X	I:C1412471
(+	I:C1412471
)	I:C1412471
allele	B:C0002085
and	O
ApoE	B:C1412481
E4	I:C1412481
allele	B:C0002085
may	O
increase	O
the	O
risk	O
of	O
the	O
development	O
of	O
premature	B:C1867743
CAD	I:C1867743
in	O
Egyptian	B:C0337801
patients	O
.	O

